Orlifit®
Therapeutic Segment:
Anti-Obesity
Generic Name:
Orlistat
Indication
Capsules
- tablet
For long-term obesity management, including weight loss, weight maintenance, together with a reduced-calorie diet, and for reducing the risk of weight regain after weight loss in patients with an initial BMI of 30kg/m² or greater. with an initial BMI of 28kg/m² or more in the presence of other risk factors ( e. g., hypertension, diabetes, dyslipidemia).